EGFR and gastric cancer: The present study investigated the cytotoxic activity of CIK cells targeted by epidermal growth factor receptor (EGFR)/CD3 BsAbs against the gastric cancer cell line SGC7901 to analyze the effect of this therapeutic strategy against gastric cancer.